DE60043216D1 - Gm-csf zur behandlung von morbus crohn - Google Patents
Gm-csf zur behandlung von morbus crohnInfo
- Publication number
- DE60043216D1 DE60043216D1 DE60043216T DE60043216T DE60043216D1 DE 60043216 D1 DE60043216 D1 DE 60043216D1 DE 60043216 T DE60043216 T DE 60043216T DE 60043216 T DE60043216 T DE 60043216T DE 60043216 D1 DE60043216 D1 DE 60043216D1
- Authority
- DE
- Germany
- Prior art keywords
- csf
- treatment
- morbus crohn
- factors
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/193—Colony stimulating factors [CSF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Ophthalmology & Optometry (AREA)
- Oncology (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Transplantation (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Studio Devices (AREA)
- Silicon Compounds (AREA)
- Treatment Of Sludge (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11984299P | 1999-02-12 | 1999-02-12 | |
PCT/US2000/003407 WO2000047195A1 (en) | 1999-02-12 | 2000-02-11 | Stimulating neutrophil function to treat inflammatory bowel disease |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60043216D1 true DE60043216D1 (de) | 2009-12-10 |
Family
ID=22386711
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60043216T Expired - Lifetime DE60043216D1 (de) | 1999-02-12 | 2000-02-11 | Gm-csf zur behandlung von morbus crohn |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1150666B1 (de) |
JP (2) | JP2002536404A (de) |
AT (1) | ATE446767T1 (de) |
AU (1) | AU764681C (de) |
CA (1) | CA2367575A1 (de) |
DE (1) | DE60043216D1 (de) |
WO (1) | WO2000047195A1 (de) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6500418B1 (en) * | 1999-02-12 | 2002-12-31 | The Washington University | Stimulating neutrophil function to treat inflammatory bowel disease |
AR044315A1 (es) * | 2003-05-16 | 2005-09-07 | Kyowa Hakko Kogyo Kk | Agente para prevenir y/o tratar enfermedades acompañadas de alteraciones de tejidos que comprende un polipeptido |
WO2005084702A1 (ja) * | 2004-03-02 | 2005-09-15 | Hokkaido Technology Licensing Office Co., Ltd. | 臓器線維症予防・治療剤 |
WO2007134907A2 (en) * | 2006-05-18 | 2007-11-29 | Bayer Schering Pharma Aktiengesellschaft | Gm-csf gene therapy for treatment of crohn's disease using an improved regulated expression system |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU594014B2 (en) * | 1984-03-21 | 1990-03-01 | Research Corporation Technologies, Inc. | Recombinant DNA molecules |
UA39161C2 (uk) * | 1984-07-06 | 2001-06-15 | Новартіс Аг | Рекомбінантний білок gm-csf для збільшення продукції гранулоцитів і макрофагів у пацієнтів, вектор і кднк, що його кодують |
ZA856108B (en) * | 1984-10-29 | 1986-10-29 | Immunex Corp | Cloning of human granulocyte-macrophage colony simulating factor gene |
WO1988010310A1 (en) * | 1987-06-25 | 1988-12-29 | Immunex Corporation | Bovine granulocyte-macrophage colony stimulating factor |
US4961926A (en) * | 1987-11-19 | 1990-10-09 | Sloan-Kettering Institute For Cancer Research | Methods for prevention and treatment of mucositis with granulocyte colony stimulating factor |
US5654186A (en) * | 1993-02-26 | 1997-08-05 | The Picower Institute For Medical Research | Blood-borne mesenchymal cells |
US5767156A (en) * | 1993-10-06 | 1998-06-16 | Peptide Technology Limited | Polyunsaturated fatty acids and uses thereof |
US5733915A (en) * | 1995-03-30 | 1998-03-31 | Glaxo Wellcome Inc. | Use of azathioprine to treat crohn's disease |
US6037324A (en) * | 1996-01-04 | 2000-03-14 | Leukosite, Inc. | Inhibitors of MAdCAM-1-mediated interactions and methods of use therefor |
US5846983A (en) * | 1996-02-09 | 1998-12-08 | Mayo Foundation For Medical Education And Research | Colonic delivery of nicotine to treat inflammatory bowel disease |
PT971735E (pt) * | 1997-04-01 | 2008-06-02 | Borody Thomas J | Métodos e composições para tratamento de doença inflamatória do intestino |
DE19835080A1 (de) * | 1998-07-27 | 2000-02-03 | Doecke Wolf Dietrich | Mittel zur Behandlung des Krankheitsbildes Morbus Crohn |
-
2000
- 2000-02-11 CA CA002367575A patent/CA2367575A1/en not_active Abandoned
- 2000-02-11 DE DE60043216T patent/DE60043216D1/de not_active Expired - Lifetime
- 2000-02-11 AT AT00913421T patent/ATE446767T1/de not_active IP Right Cessation
- 2000-02-11 WO PCT/US2000/003407 patent/WO2000047195A1/en active Search and Examination
- 2000-02-11 EP EP00913421A patent/EP1150666B1/de not_active Expired - Lifetime
- 2000-02-11 JP JP2000598148A patent/JP2002536404A/ja not_active Withdrawn
- 2000-02-11 AU AU34871/00A patent/AU764681C/en not_active Ceased
-
2005
- 2005-04-21 JP JP2005124264A patent/JP2005225890A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2367575A1 (en) | 2000-08-17 |
ATE446767T1 (de) | 2009-11-15 |
JP2005225890A (ja) | 2005-08-25 |
EP1150666A4 (de) | 2003-07-02 |
AU3487100A (en) | 2000-08-29 |
EP1150666B1 (de) | 2009-10-28 |
WO2000047195A1 (en) | 2000-08-17 |
JP2002536404A (ja) | 2002-10-29 |
AU764681C (en) | 2005-07-07 |
AU764681B2 (en) | 2003-08-28 |
EP1150666A1 (de) | 2001-11-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY155218A (en) | Small molecules useful in the treatment of inflammatory disease | |
IL267381A (en) | A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders | |
EA200601575A1 (ru) | Казеиновые пептиды и их терапевтическое применение | |
DE69030880D1 (de) | Zusammensetzung zur Stimulierung des Immunsystems | |
FR14C0051I2 (fr) | Dialkylfumarates pour le traitement de maladies autoimmunes | |
DK1390049T3 (da) | Sammensætninger til behandling af dyresygdomme og -syndromer omfattende transferfaktor | |
ATE87214T1 (de) | Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc). | |
SG146666A1 (en) | Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders | |
ATE302003T1 (de) | Zubereitungen enthaltend apomorphin und sildenafil und ihre verwendung zur behandlung von erektiler dysfunktion | |
IL181629A0 (en) | Compositions and methods for the diagnosis and tretment of tumor | |
NO20014415D0 (no) | Medisinske preparater til behandling av <alfa>-galaktosidase- A-defisiens | |
DE60121303D1 (de) | Mittel, wie nikotinamide oder cadpr zur behandlung von hautkrankheiten | |
EA200600921A1 (ru) | Способы и композиции с применением талидомида для лечения и менеджмента рака и других заболеваний | |
BR0010702A (pt) | Novas quinonas como terapias de doenças | |
ATE374620T1 (de) | Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen | |
DE60043216D1 (de) | Gm-csf zur behandlung von morbus crohn | |
WO2006022612A3 (en) | Methods of using regenerative cells in the treatment of stroke and related diseases and disorders | |
ATE320270T1 (de) | Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren | |
ATE81467T1 (de) | Immunosuppression bei der auf immunotoxin basierten behandlung von menschen. | |
MX2021012543A (es) | Compuestos de indoles quirales y su uso. | |
ATE81462T1 (de) | Glykosaminoglykan zur behandlung von diabetischer mikroangiopathie. | |
DE69929616D1 (de) | Oxyhuminsäure und ihre verwendung zur behandlung von verschiedenenen störungen | |
HUP0003845A2 (hu) | Antimikrobiális 8a-azalidok alkalmazása | |
MXPA05008293A (es) | Composiciones y metodos para el diagnostico y tratamiento de tumores. | |
Pierpaoli | Effect of human transferrin on the engraftment of allogeneic bone marrow in various strans of lethally irradiated mice |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition |